Physician profile
Rachel Thomas
NPI 1275160657
$3,758.63
in general payments reported to CMS, 2019-2025
7 companies · $2,951 in 2025
The $2,951 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.67 · 2023: $378 · 2024: $389 · 2025: $2,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,938 · Food and Beverage: $1,605 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,938.02 |
| Food and Beverage | $1,604.95 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,740.62 | 2023-2025 | Mako, Gamma, Variax |
| Zimmer Biomet Holdings, INC. | $464.15 | 2025 | Rosa, Comprehensive Shoulder System |
| Globus Medical, INC. | $167.74 | 2025 | Anthem |
| Innovation Technologies INC | $163.62 | 2023 | Irrisept |
| Regeneron Healthcare Solutions, INC. | $115.81 | 2025 | Dupixent |
| Novus Surgical Consultants | $66.02 | 2024-2025 | |
| Novus Surgical Solutions LLC | $40.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.